Prognostic implications of vascular complications following PCI

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 1, 2009, Pages 64-73

  Applegate, Robert ^a   Sacrinty, Matthew ^a   Little, William ^a   Gandhi, Sanjay ^a   Kutcher, Michael ^a   Santos, Renato ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Percutaneous coronary intervention; Vascular complications

Indexed keywords

ACETYLSALICYLIC ACID; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FALSE ANEURYSM; FEMALE; HAZARD RATIO; HEART INFARCTION; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; VASCULAR ACCESS; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PUNCTURES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VASCULAR DISEASES;

EID: 68949215229     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21960     Document Type: Article

References (28)

1. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol 2007;100: 1364-1369.
2. Jani SM, Smith DE, Share D, Kline-Rogers E, Khanal S, O'Donnell MJ, Gardin J, Moscucci M. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infaction undergoing percutaneous coronary intervention. Clin Cardiol 2007;30:II49-II56.
3. Kim P, Dixon S, Eisenbrey AB, O'Malley B, Boura J, O'Neill W. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol 2007;30:II35-II43.
4. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB, III, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY trial. J Am Coll Cardiol 2007;49:1362-1368.
5. Moscucci M, Fox KAA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, White K, Goldberg RJ. Predictors of major bleeding in acute coronary syndromes: The global registry of acute coronary events (GRACE). Eur Heart J 2003;24:1815-1823.
6. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann F-J, Schomig A, Kastrati A. Periprocedural bleeding and 1-year outcome after percuntaneous coronary interventions: Appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008;51:690-697.
7. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Harrington RA. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:809-816.
8. Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lincoff AM, Stone GW. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007;28:1936-1945.
9. Wallace TW, Rao SV. The challenge of defining bleeding among patients with acute coronary syndromes. Clin Cardiol 2007;30:II16-II23.
10. Applegate RJ, Sacrinty M, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv 2006;67:556-562.
11. Piper WD, Malenka DJ, Ryan TJ, Jr., Shubrooks SJ, Jr, O'Connor GT, Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA, Jr, Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath PD, O'Mears JR, Wennberg DE, for the Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003;145:1022-1029.
12. Berry C, Kelly J, Cobbe SM, Eteiba H. Comparison of femoral bleeding complications after coronary angiography versus percutaneous coronary intervention. Am J Cardiol 2004;94:361-363.
13. Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the national heart, lung, and blood institute dynamic registry. Catheter Cardiovasc Intervent 2007;69:961-966.
14. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998-2007. JACC Intv 2008;1:317-326.
15. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-Label" stent therapy: 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2008;51:607-614.
16. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression. J Invasiv Cardiol 2007;19:164-170.
17. Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, Braden GA, Rankin KM, Kutcher MA. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83.
18. American College of Cardiology. National Cardiovascular Data Registry Module Version 3.0, 2004. Availabe at http://www.accncdR.com/wenNCDR/ NCDRDocuments/datadictdefsonlyv30.pdf American College of Cardiology. 5-1-2008. Accessed 6/01/08.
19. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: Systematic review and meta-analysis. JAMA 2004;291:350-357.
20. Tavris DR, Gallauresi BA, Lin B, Rich SE, Shaw RE, Weintraub WS, Brindis RG, Hewitt K. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol 2004;16:459-64.
21. Waksman R, King SB III, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZMB, Weintraub WS. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
22. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-641.
23. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:196-202.
24. Farouque HMO, Tremmel JA, Shabari FR, Aggarwal M, Fearon WF, Ng MKC, Rezaee M, Yeung AC, Lee DP. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 2005;45: 363-368.
25. Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:541-545.
26. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, for the REPLACE-, 2 Investigators. Long-term efficacy of bivalirudin and provisional glycoprotien IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004;292:696-703.
27. Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ, ACUITY Investigators. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: One-year results from the ACUITY trial. JAMA 2007;298:2497-2506.
28. Resnic FS, Arora N, Matheny M, Reynolds MR. A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention. Am J Cardiol 2007;99: 766-770.